These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 34948035)

  • 41. Pharmacological inhibition of the primary endocannabinoid producing enzyme, DGL-α, induces autism spectrum disorder-like and co-morbid phenotypes in adult C57BL/J mice.
    Fyke W; Alarcon JM; Velinov M; Chadman KK
    Autism Res; 2021 Jul; 14(7):1375-1389. PubMed ID: 33886158
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The endocannabinoid system and neurogenesis in health and disease.
    Galve-Roperh I; Aguado T; Palazuelos J; Guzmán M
    Neuroscientist; 2007 Apr; 13(2):109-14. PubMed ID: 17404371
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transcriptomic and proteomic profiling of glial versus neuronal Dube3a overexpression reveals common molecular changes in gliopathic epilepsies.
    Hope KA; Johnson D; Miller PW; Lopez-Ferrer D; Kakhniashvili D; Reiter LT
    Neurobiol Dis; 2020 Jul; 141():104879. PubMed ID: 32344153
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endocannabinoid system: Role in blood cell development, neuroimmune interactions and associated disorders.
    Sharma DS; Paddibhatla I; Raghuwanshi S; Malleswarapu M; Sangeeth A; Kovuru N; Dahariya S; Gautam DK; Pallepati A; Gutti RK
    J Neuroimmunol; 2021 Apr; 353():577501. PubMed ID: 33571815
    [TBL] [Abstract][Full Text] [Related]  

  • 45. From endocannabinoid profiling to 'endocannabinoid therapeutics'.
    Ligresti A; Petrosino S; Di Marzo V
    Curr Opin Chem Biol; 2009 Jun; 13(3):321-31. PubMed ID: 19497779
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The endocannabinoid system in gp120-mediated insults and HIV-associated dementia.
    Bari M; Rapino C; Mozetic P; Maccarrone M
    Exp Neurol; 2010 Jul; 224(1):74-84. PubMed ID: 20353779
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glia and epilepsy: experimental investigation of antiepileptic drugs in an astroglia/microglia co-culture model of inflammation.
    Dambach H; Hinkerohe D; Prochnow N; Stienen MN; Moinfar Z; Haase CG; Hufnagel A; Faustmann PM
    Epilepsia; 2014 Jan; 55(1):184-92. PubMed ID: 24299259
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cannabinoid signaling in glial cells.
    Stella N
    Glia; 2004 Dec; 48(4):267-77. PubMed ID: 15390110
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glial endocannabinoid system in pain modulation.
    Wang J
    Int J Neurosci; 2019 Jan; 129(1):94-100. PubMed ID: 30084280
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting the endocannabinoid system: future therapeutic strategies.
    Aizpurua-Olaizola O; Elezgarai I; Rico-Barrio I; Zarandona I; Etxebarria N; Usobiaga A
    Drug Discov Today; 2017 Jan; 22(1):105-110. PubMed ID: 27554802
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of glia in epilepsy, intellectual disability, and other neurodevelopmental disorders in tuberous sclerosis complex.
    Wong M
    J Neurodev Disord; 2019 Dec; 11(1):30. PubMed ID: 31838997
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Glial control of endocannabinoid heterosynaptic modulation in hypothalamic magnocellular neuroendocrine cells.
    Di S; Popescu IR; Tasker JG
    J Neurosci; 2013 Nov; 33(46):18331-42. PubMed ID: 24227742
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.
    Murillo-Rodriguez E; Pastrana-Trejo JC; Salas-Crisóstomo M; de-la-Cruz M
    CNS Neurol Disord Drug Targets; 2017; 16(4):370-379. PubMed ID: 28240187
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endocannabinoid-Mediated Control of Neural Circuit Excitability and Epileptic Seizures.
    Sugaya Y; Kano M
    Front Neural Circuits; 2021; 15():781113. PubMed ID: 35046779
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Longitudinal positron emission tomography imaging of glial cell activation in a mouse model of mesial temporal lobe epilepsy: Toward identification of optimal treatment windows.
    Nguyen DL; Wimberley C; Truillet C; Jego B; Caillé F; Pottier G; Boisgard R; Buvat I; Bouilleret V
    Epilepsia; 2018 Jun; 59(6):1234-1244. PubMed ID: 29672844
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vivo activation of endocannabinoid system in temporal lobe epilepsy with hippocampal sclerosis.
    Goffin K; Van Paesschen W; Van Laere K
    Brain; 2011 Apr; 134(Pt 4):1033-40. PubMed ID: 21303859
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cannabinoid receptors and endocannabinoids: role in neuroinflammatory and neurodegenerative disorders.
    Bisogno T; Di Marzo V
    CNS Neurol Disord Drug Targets; 2010 Nov; 9(5):564-73. PubMed ID: 20632970
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of glial cells in epilepsy.
    Heuser K; Szokol K; Taubøll E
    Tidsskr Nor Laegeforen; 2014 Jan; 134(1):37-41. PubMed ID: 24429754
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system.
    Aymerich MS; Aso E; Abellanas MA; Tolon RM; Ramos JA; Ferrer I; Romero J; Fernández-Ruiz J
    Biochem Pharmacol; 2018 Nov; 157():67-84. PubMed ID: 30121249
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional neuroanatomy of the endocannabinoid system.
    Pazos MR; Núñez E; Benito C; Tolón RM; Romero J
    Pharmacol Biochem Behav; 2005 Jun; 81(2):239-47. PubMed ID: 15936805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.